Intraoperative online pachymetry important safety feature

Article

An initial clinical evaluation of the new ESIRIS excimer laser with integrated, online, optical coherence pachymetry (Schwind), showed that constant corneal monitoring is an important safety feature for LASIK procedures, Kumar J. Doctor said.

An initial clinical evaluation of the new ESIRIS excimer laser with integrated, online, optical coherence pachymetry (Schwind), showed that constant corneal monitoring is an important safety feature for LASIK procedures, Kumar J. Doctor said.

The study recruited 25 patients with myopia and myopic astigmatism. Optical pachymetry assessed corneal thickness and observed all eyes during all the steps of LASIK. The study used a 130 micron head for 46 eyes and 110 micron head for four eyes using the Carriazo Pendular microkeratome.

Attempted mean spherical equivalent refraction was 4.0 D (+/-3.0 D) and cylinder was, -1.0D (+/-0.50 D), with a mean calculated stromal depth of 80 (+/- 22) microns. Mean flap thickness was 115 (+/-15) microns and in every case achieved a residual corneal stroma of more than 250 microns. The immediate postoperative evaluation showed swelling of the cornea.

Pre- and postoperative central cornea thickness measurements showed a mean decrease from 503 microns (range: 431-599) to 423 (387-512) microns.

Dr Doctor of the Doctor Eye Institute, Mumbai, India, said safety required measurement of the flap thickness directly after the flap cut and it needed measurement of the ablation progress during LASIK treatment for a better control of the residual stromal thickness.

"This system of online pachymetry during LASIK is reproducible to the extent of 1 to 2 microns," said Dr Doctor. "Evaluation of residual corneal thickness is crucial to prevent corneal ectasia," he insisted, adding that the Schwind laser is a good and accurate system.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.